Popular GLP-1 medications approved for weight loss, diabetes, and heart disease may have untapped potential to treat ...

The first study to assess how weight-loss drugs affect the whole of human health has discovered an "eye-opening" impact on ...

The findings, based on an analysis of records from 2.5 million VA patients, support much of what scientists already suspected ...

Federal officials are targeting the blockbuster drugs as part of their ongoing initiative to lower drug costs.

The Biden administration announced Friday that Ozempic, Wegovy and 13 additional drugs will now be covered under Medicare ...

Websites selling compounded versions of popular weight-loss drugs from Novo Nordisk and Eli Lilly to U.S. consumers often do ...

The government is expected to pay lower prices for Ozempic and Wegovy starting in 2027. The Trump administration will decide ...

The Biden administration said Medicare will negotiate discounts with drug companies on 15 drugs prescribed to treat cancer, ...

Novo Nordisk said on Friday a late-stage trial with a high-dose version of its weight loss drug semaglutide helped overweight ...

The Biden administration says popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of ...

Demand for weight-loss medications sold under brand names such as Ozempic and Wegovy continues to surge, with a study ...